dual glp-1/gip receptor agonists and Triple Gut Peptide on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Effects, working principles and target

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

Andreozzi F, Raciti GA, Nigro C, Mannino GC, Procopio T, Davalli AM, et al

Sanguigno L., Guida N., Anzilotti S., et al., Stroke by Inducing HDAC9Dependent Deacetylation of HIF1 and Sp1, Promotes TfR1 Transcription and GPX4 Reduction, Thus Determining Ferroptotic Neuronal Death, International Journal of Biological Sciences 19 (2023): 26952710

This article covers the biological pathways each compound affects, the clinical evidence for weight outcomes, and the practical implications for patients choosing between supplementation and prescription therapy